Advertisement

Cancer Causes & Control

, Volume 3, Issue 1, pp 49–55 | Cite as

Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma

  • Linda Morris Brown
  • George D. Everett
  • Robert Gibson
  • Leon F. Burmeister
  • Leonard M. Schuman
  • Aaron Blair
Research Papers

Population-based case-control interview studies of 622 White men with non-Hodgkin's lymphoma and 820 controls from Iowa and Minnesota (United States) and 173 White men with multiple myeloma and 452 controls from Iowa offered the opportunity to investigate the relationship of these cancers with smoking. Risks were significantly elevated for all lymphoma (odds ratio [OR]=1.4), high-grade lymphoma (OR=2.3), and unclassified lymphoma (OR=2.8) for cigarette smokers. Dose-response gradients were not seen with intensity of cigarette use, but risks for these subtypes were greatest for cigarette smokers of longest duration. Similar elevations in risks were seen for tobacco users. The risk of multiple myeloma was not significantly elevated for either tobacco users or cigarette smokers. The findings from this study confirm the lack of an association between smoking and multiple myeloma and provide some support for an association between tobacco use and certain subtypes of non-Hodgkin's lymphoma.

Key words

Case-control study cigarettes epidemiology etiology multiple myeloma non-Hodgkin's lymphoma smoking tobacco United States 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Austin H, Cole P. Cigarette smoking and leukemia. J Chron Dis 1986; 39: 417–21.Google Scholar
  2. 2.
    Wald N. Smoking and leukemia (Editorial). Br Med J 1988; 297: 638.Google Scholar
  3. 3.
    Austin H, Cole P. (Response to letter by Brownson.) J Clin Epidemiol 1989; 42: 1027–8.Google Scholar
  4. 4.
    Newell GR. Cigarette smoking as a cause of leukemia (Editorial)? Cancer Bull 1990; 42: 197–9.Google Scholar
  5. 5.
    Heath CWJr. Cigarette smoking and hematopoietic cancer (Editorial). JNCI 1990; 82: 1800–01.Google Scholar
  6. 6.
    Brown LM, Blair A, Gibson R, Everett GD, et al. Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res 1990; 50: 6585–91.Google Scholar
  7. 7.
    Burmeister LF. Cancer in Iowa farmers: recent results. Am J Ind Med 1990; 18: 295–301.Google Scholar
  8. 8.
    Pottern LM, Linet M, Blair A, et al. Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leukemia Res 1991; 15: 305–14.Google Scholar
  9. 9.
    Waksberg JE. Sampling methods for random digit dialing. J Am Stat Assoc 1978; 73: 40–6.Google Scholar
  10. 10.
    National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas, summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–35.Google Scholar
  11. 11.
    Dick F, VanLier S, Banks P, et al. Use of the Working Formulation for non-Hodgkin's lymphoma in epidemiologic studies: agreement between reported diagnoses and a panel of experienced pathologists. JNCI 1987; 78: 1137–44.Google Scholar
  12. 12.
    Persey C, O'Conor G, Ries LG, Jaffe ES. Non-Hodgkin's lymphomas: application of the International Classification of Disease for Oncology (ICD-O) to the Working Formulation. Cancer 1984; 54: 1435–8.Google Scholar
  13. 13.
    McLaughlin JK, Blot WJ, Mehl ES, et al. Problems in the use of dead controls in case-control studies. I. General results. Am J Epidemiol 1985; 121: 131–9.Google Scholar
  14. 14.
    Dixon WJ, ed. BMDP Statistical Software Manual Volume 2. Berkeley, CA: University of California Press, 1990; 1013–77.Google Scholar
  15. 15.
    Williams RR, Horm HW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. JNCI 1977; 58: 525–47.Google Scholar
  16. 16.
    Franceschi S, Serraino D, Bidoli E, et al. The epidemiology of non-Hodgkin's lymphoma in the north-east of Italy: a hospital-based case-control study. Leukemia Res 1989; 13: 465–72.Google Scholar
  17. 17.
    Paffenbarger RS, Wing AL, Hyde RT. Characteristics in youth predictive of adult-onset malignant lymphomas, melanomas, and leukemias: brief communication. JNCI 1978; 60: 89–92.Google Scholar
  18. 18.
    Hoar SK, Blair A, Holmes FF, et al. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA 1986; 256: 1141–7.Google Scholar
  19. 19.
    Cartwright RA, McKinney PA, O'Brien C, et al. Non-Hodgkin's lymphoma: case control epidemiologic study in Yorkshire. Leukemia Res 1988; 12: 81–8.Google Scholar
  20. 20.
    Archimbaud E, Maupas J, Lecluze-Palazzolo C, Fiere D, Viala J. Influence of cigarette smoking on the presentation and course of chronic myelogenous leukemia. Cancer 1989; 60: 2060–5.Google Scholar
  21. 21.
    Herr R, Ferguson J, Myers N, Rovira D, Robinson WA. Cigarette smoking, blast crisis, and survival in chronic myeloid leukemia. Am J Hematol 1990; 34: 1–4.Google Scholar
  22. 22.
    Checkoway H, Pearce NE, Crawford-Brown DJ. Research Methods in Occupational Epidemiology. New York: Oxford University Press, 1989: 80–2.Google Scholar
  23. 23.
    Hardell L, Eriksson M, Lenner P, Lundgren E, Malignant lymphoma and exposure to chemicals especially organic solvents, chlorophenols and phenoxy acids: a case-control study. Br J Cancer 1981; 43: 169–76.Google Scholar
  24. 24.
    Vianna NJ, Polan A. Lymphomas and occupational benzene exposure. Lancet 1979; i: 1394–5.Google Scholar
  25. 25.
    Olsson H, Brandt L. Risk on non-Hodgkin's lymphoma among men occupationally exposed to organic solvents. Scand J Work Environ Health 1988; 14: 246–51.Google Scholar
  26. 26.
    Hayes RB, Blair A, Steward PS, Herricks RF, Mahar H. Mortality of US embalmers and funeral directors. Am J Ind Med 1990; 18: 641–52.Google Scholar
  27. 27.
    Stedman RL. The chemical composition of tobacco and tobacco smoke. Chem Rev 1968; 68: 153–207.Google Scholar
  28. 28.
    International Agency for Research on Cancer. Tobacco Smoking. Lyon, France: IARC, 1986; IARC Monogr Eval Carcinog Risk Chem Humans, Vol. 38: 83–119.Google Scholar
  29. 29.
    Wallace L, Pellizzar E, Hartwell TD, Perritt R, Ziegenfus R. Exposures to benzene and other volatile compounds from active and passive smoking. Arch Environ Health 1987; 42: 272–9.Google Scholar
  30. 30.
    Brandt L, Kristoffersson U, Olsson H, Mitelman F. Relation between occupational exposure to organic solvents and chromosome aberrations in non-Hodgkin's lymphoma. Eur J Haematol 1989; 49: 298–302.Google Scholar
  31. 31.
    Corre F, Lellouch J, Schwartz D. Smoking and leukocyte counts. Results of an epidemiologic survey. Lancet 1971; ii: 632–3.Google Scholar
  32. 32.
    Friedman GD, Siegelaub AB, Seltzer CC, Feldman R, Collen MF. Smoking habits and the leukocyte count. Arch Environ Health 1973; 26: 137–43.Google Scholar
  33. 33.
    Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking. Med J Aust 1983; ii: 425–9.Google Scholar
  34. 34.
    Tollerud DJ, Clark JW, Brown LM, et al. The effects of cigarette smoking on T cell subsets: a population-based survey of healthy Caucasians. Am Rev Respir Dis 1989; 139: 1446–51.Google Scholar
  35. 35.
    Tollerud DJ, Clark JW, Brown LM, et al. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 1989; 139: 194–8.Google Scholar
  36. 36.
    Filipovich AH, Spector BD, Kersey J. Immunodeficiency in humans as a risk factor in the development of malignancy. Prev Med 1980; 9: 252–9.Google Scholar
  37. 37.
    Greene MH. Non-Hodgkin's lymphoma and mycosis fungoides. In: Schottenfeld D, Fraumeni JFJr, eds. Cancer Epidemiology and Prevention. Philadelphia, PA: WB Saunders Co., 1982: 754–78.Google Scholar
  38. 38.
    Kersey JH, Shapiro RS, Filipovich AH. Relationship of immunodeficiency to lymphoid malignancy. Pediatr Infect Dis 1988; 7: S10–2.Google Scholar
  39. 39.
    Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. N Engl J Med 1984; 311: 565–70.Google Scholar
  40. 40.
    Gallagher RP, Spinelli JJ, Elwood JM, Skipper DH. Allergies and agricultural exposure as risk factors for multiple myeloma. Br J Cancer 1983; 48: 853–7.Google Scholar
  41. 41.
    Boffetta P, Stellman SD, Garfinkel L. A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int J Cancer 1989; 43: 554–9.Google Scholar
  42. 42.
    Flodin U, Fredriksson M, Persson B. Multiple myeloma and engine exhausts, fresh wood, and creosote: a case-referent study. Am J Ind Med 1987; 12: 519–29.Google Scholar
  43. 43.
    Linet MS, Harlow SD, McLaughlin JK. A case-control study of multiple myeloma in whites: Chronic antigenic stimulation, occupation, and drug use. Cancer Res 1987; 47: 2978–81.Google Scholar
  44. 44.
    Heineman EF, Zahm SH, McLaughlin JK, Vaught JB, Hrubec Z. A prospective study of tobacco use and multiple myeloma: evidence against an association. Cancer Causes Control 1992; 3: 31–36.Google Scholar
  45. 45.
    Mills PK, Newell GR, Beeson WL, Fraser GE, Phillips RL. History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist Health study. JNCI 1990; 82: 1832–6.Google Scholar
  46. 46.
    Heath CWJr. The leukemias. In: Schottenfeld D, Fraumeni JFJr, eds. Cancer Epidemiology and Prevention. Philadelphia, PA: WB Saunders Co., 1982: 728–38.Google Scholar
  47. 47.
    Blattner WA. Multiple myeloma and macroglobulinemia. In: Schottenfeld D, Fraumeni JFJr, eds. Cancer Epidemiology and Prevention. Philadelphia, PA: WB Saunders Co., 1982: 795–813.Google Scholar

Copyright information

© Rapid Communications of Oxford Ltd 1992

Authors and Affiliations

  • Linda Morris Brown
  • George D. Everett
  • Robert Gibson
  • Leon F. Burmeister
  • Leonard M. Schuman
  • Aaron Blair

There are no affiliations available

Personalised recommendations